CSIMarket
 
Orthopediatrics Corp  (NASDAQ: KIDS)
Other Ticker:  
 
 
Price: $20.9700 $-0.01 -0.048%
Day's High: $21.55 Week Perf: -8.94 %
Day's Low: $ 20.87 30 Day Perf: -15.99 %
Volume (M): 144 52 Wk High: $ 35.75
Volume (M$): $ 3,009 52 Wk Avg: $27.40
Open: $21.40 52 Wk Low: $20.37



 Market Capitalization (Millions $) 484
 Shares Outstanding (Millions) 23
 Employees 247
 Revenues (TTM) (Millions $) 205
 Net Income (TTM) (Millions $) -38
 Cash Flow (TTM) (Millions $) 13
 Capital Exp. (TTM) (Millions $) 40

Orthopediatrics Corp
OrthoPediatrics Corp. is a medical device company that focuses on designing and manufacturing orthopedic implants, instruments, and surgical techniques that are specifically designed for children. Founded in 2006, OrthoPediatrics Corp. is headquartered in Warsaw, Indiana with offices in the United Kingdom, Australia, and Japan. The companyes mission is to improve the lives of children with musculoskeletal disorders and injuries, by providing innovative orthopedic solutions that cater to their unique needs.

OrthoPediatrics Corp. offers a wide range of pediatric-specific orthopedic products, including plates, screws, nails, and intramedullary rods. These devices are used to treat various conditions such as limb deformities, fractures, spinal disorders, and sports injuries. The company also provides surgeons with specialized instrument sets that are designed for pediatric procedures, which aid in enhancing surgical outcomes and reducing operating times.

A key differentiating factor of OrthoPediatrics Corp. is its dedication to advancing orthopedic care for children. The company has partnered with leading pediatric orthopedic surgeons and institutions to develop new surgical techniques and technologies that address the unique challenges of treating pediatric patients. This includes the development of the TELEMED, a remote surgical system that enables surgeons to provide real-time consultations, training, and support to colleagues in other locations.

OrthoPediatrics Corp. has received several accolades for its innovative products and commitment to improving orthopedic care for children. In 2017, the company was named the fastest-growing public company in Indiana by the Indianapolis Business Journal. OrthoPediatrics Corp. was also awarded the Medical Device Engineering Breakthrough Award in 2018 by the Medical Design & Outsourcing magazine.

In summary, OrthoPediatrics Corp. is a medical device company that specializes in designing and manufacturing orthopedic products that cater to the unique needs of pediatric patients. With a focus on innovation and a commitment to advancing pediatric orthopedic care, OrthoPediatrics Corp. has established itself as a leader in this specialized field.


   Company Address: 2850 Frontier Drive Warsaw 46582 IN
   Company Phone Number: 268-6379   Stock Exchange / Ticker: NASDAQ KIDS


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
EW        1.23% 
GMED   -2.6%    
MDT   -0.36%    
SYK   -1.08%    
TFX   -0.32%    
ZBH   -4.33%    
• View Complete Report
   



Product Service News

Strategic Bracing OrthoPediatrics Pursuit of Growth amid Financial Challenges,

Published Tue, Nov 26 2024 9:05 PM UTC

OrthoPediatrics Corp. Braces for Growth with DF2 Innovations In the niche yet steadily expanding market of pediatric orthopedics, OrthoPediatrics Corp. has unveiled significant enhancements to its DF2 Brace a cornerstone product of their Specialty Bracing business. This development underscores the company?s commitment to its mission: advancing pediatric orthopedic care throu...

Product Service News

OrthoPediatrics Corp. Launches Enabling Technologies Division Pioneering Innovations in Pediatric Orthopedics

Published Thu, Sep 12 2024 11:05 AM UTC

In a strategic move poised to reshape the landscape of pediatric orthopedic care, OrthoPediatrics Corp. has officially announced the launch of its Enabling Technologies Division. The initiative aims to develop cutting-edge solutions that enhance surgical efficiencies and improve patient outcomes in children with musculoskeletal conditions. Founded with a mission to address t...

Financing Agreement

OrthoPediatrics Corp. Secures $100 Million in Capital through Private Financing

Published Mon, Aug 5 2024 8:10 PM UTC



OrthoPediatrics Corp., a leading orthopedic medical device company specializing in pediatric orthopedics, has recently announced a major private financing initiative. The company aims to raise up to $100 million in capital through a combination of term loans and a private placement of convertible notes. This infusion of funds will be instrumental in driving the com...

Announcement

OrthoPediatrics Corp. Solidifies Long-Term Partnership as Emerald Sponsor at the 2024 EPOSNA Annual Meeting

Published Wed, May 15 2024 8:05 PM UTC

OrthoPediatrics Corp., a renowned orthopedic company, has reaffirmed its commitment to the orthopedic community by reinforcing its long-term sponsorship as an Emerald Sponsor at the 2024 EPOSNA Annual Meeting. This continued partnership serves as a testament to OrthoPediatrics Corp. s dedication to advancing pediatric orthopedic care and supporting professional development w...

Orthopediatrics Corp

Orthopediatrics Corp Surges in Revenue But Fails to Reach Profitability in Fiscal Period Ending March 31, 2024

Orthopediatrics Corp (Nasdaq: KIDS) recently reported its financial results for the fiscal period ending March 31, 2024. Despite a net shortfall per share of $-0.34, the company witnessed a significant surge in revenue, with a growth rate of 39.844% from the corresponding financial reporting period a year ago. This growth rate outperformed most of its competitors in the Medical Equipment & Supplies industry, where the average top-line advance was only 6.11% relative to the first quarter of 2023.
In the previous financial reporting period, Orthopediatrics Corp achieved a revenue of $37.15 million and a shortfall per share of $-0.28. However, in the first quarter of 2024, the company experienced a higher net shortfall of $-7.805 million compared to $-6.806 million in the same period last year.







Orthopediatrics's Segments
U S    79.01 % of total Revenue
International    21.94 % of total Revenue
Trauma and deformity    69.63 % of total Revenue
Scoliosis    28.92 % of total Revenue
Sports medicine other    2.4 % of total Revenue

  Orthopediatrics Outlook

On August 5 2024 the Orthopediatrics provided following guidance

OrthoPediatrics Corp. has released its financial results for the second quarter of 2024, showcasing a remarkable 33% increase in revenue compared to the same period last year. This impressive growth underscores the company's strong performance and solidifies its position in the pediatric orthopedic market.

In this latest report, OrthoPediatrics Corp. also reaffirmed its revenue guidance for the full year 2024, indicating confidence in its business strategy and market potential. While specific revenue figures or ranges were not disclosed, the company's leadership remains optimistic about achieving its financial targets.

Overall, the record revenue reported for the second quarter not only reflect...





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com